pharmaceutical investing Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program
pharmaceutical investing Approval of Linzess Tablets 0.25 mg in Japan for Additional Indication of Chronic Constipation
Steadright Critical Minerals Inc. to Acquire up to 75% Interest in the Péribonka Ree-Niobium Carbonatite Project, Saguenay-Lac-St-Jean Region, Québec
Prismo Metals Announces Listing of Blade Resources on the CSE Prismo Metals Owns 6,755,000 Shares of Blade Resources
Goldgroup Highlights Its Two Producing Mines and Significant Growth Potential Across the Don David Gold Complex in Mexico
